NSB — Neuroscientific Biopharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$6.94m
- AU$3.60m
- AU$5.06m
- 75
- 68
- 23
- 57
Annual cashflow statement for Neuroscientific Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.085 | 0.032 | 0.028 | 0.068 | 0.107 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.41 | -2.28 | -2.6 | -6.94 | -2.3 |
| Capital Expenditures | -0.019 | -0.002 | -0.03 | -0.004 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.019 | -0.002 | -0.03 | -0.004 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 5.93 | 0.961 | 13.5 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.51 | -1.32 | 10.9 | -6.95 | -2.3 |